Clinical Trials Browser

Phase 2 × OTHER × Neurofibromatoses × Clear all

Melanoma, Neurofibromatoses

NCT03231306 2025-05-02

NF108-BINI

Phase 2 Completed

45 enrolled 8 charts

CNS

Neurofibroma, Neurofibromatosis 1, Peripheral Nervous System Neoplasms, Neurofibromatoses, Neurofibroma, Plexiform

NCT02101736 2023-05-24

NF105-CABO

Phase 2 Completed

45 enrolled 10 charts

CNS

Neurofibromatoses, Neurofibroma, Plexiform

NCT01402817 2018-03-14

Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

Phase 2 Terminated

19 enrolled 8 charts

CNS

Neurofibromatoses, Neurofibroma, Plexiform

NCT01673009 2016-04-06

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Phase 2 Completed

36 enrolled 8 charts

CNS

Neurofibromatoses

NCT00589784 2016-01-25

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase 2 Completed

50 enrolled 6 charts

CNS

Brain Neoplasms, Meningioma, Neurofibromatosis 1, Neurofibromatosis 2, Central Nervous System Neoplasms, Neurofibromatoses, Hemangioblastoma

NCT01412892 2014-11-14

NFitor

Phase 2 Completed

30 enrolled

CNS

Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

NCT00754780 2012-03-19

Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1

Phase 2 Completed

24 enrolled

CNS

Neurofibromatoses, Neurofibroma, Plexiform

Clinical Trials

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

NF108-BINI

NF105-CABO

Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

NFitor

Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1